PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

NCT01899599 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Epithelial Cancer Recurrent
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: PankoMab-GEX
DRUG: Placebo

Sponsor

Glycotope GmbH